Assessing risk: Data from montelukast clinical trials

J Allergy Clin Immunol. 2009 Oct;124(4):697-8. doi: 10.1016/j.jaci.2009.09.001.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Acetates / adverse effects*
  • Acetates / therapeutic use
  • Anti-Asthmatic Agents / adverse effects*
  • Anti-Asthmatic Agents / therapeutic use
  • Asthma / complications*
  • Asthma / drug therapy
  • Asthma / immunology
  • Humans
  • Leukotriene Antagonists / adverse effects*
  • Leukotriene Antagonists / therapeutic use
  • Mental Disorders / chemically induced
  • Mental Disorders / epidemiology
  • Quinolines / adverse effects*
  • Quinolines / therapeutic use
  • Risk Assessment
  • Suicide*

Substances

  • Acetates
  • Anti-Asthmatic Agents
  • Leukotriene Antagonists
  • Quinolines
  • montelukast